News » Archives » February 2016

Rare Disease Day brings researchers, clinicians and families together

Author: Shadia Ajam and Marissa Gebhard

rare

This past Friday and Saturday (February 26-27), the Boler-Parseghian Center for Rare and Neglected Diseases hosted a research symposia and community discussion on rare diseases. Over 100 researchers, families, and clinicians came together to share insights into rare diseases such as Niemann-Pick Type C, Sphrintzen Goldberg syndrome, Rett syndrome, primary lateral sclerosis, Fragile X, Angelman syndrome, Pompe disease, and others.

Read More

Fr. Hesburgh's impact on UNDERC

Author: Gene Stowe

underc3_square

Notre Dame’s nearly 8,000-acre Land O’Lakes property in Wisconsin, originating with a 1,000-acre gift from philanthropist Martin J. Gillen in the 1930s and vastly expanded by Father Hesburgh, has been the site of high-impact gatherings hosted by Hesburgh. In 1959, a group of Northern and Southern political leaders who happened to be fishermen hammered out an agreement that became the basis of the Civil Rights Act; in 1967, a global collection of top educators issued the Land O’ Lakes Statement on Catholic higher education in America.

Read More

Bringing legendary science faculty to Notre Dame

Author: Gene Stowe

theodore_hesburgh

During the one year anniversary of the death of Fr. Hesburgh, the College of Science recalls and appreciates the impact that he had on science at Notre Dame.
 
When former Notre Dame President Father John J. Cavanaugh challenged “Where are the Catholic Salks, Oppenheimers, and Einsteins?” in a widely-read essay in the late 1950s, Father Theodore Hesburgh was already in the process of providing an answer. In both direct action, from building facilities to recruiting top scholars, and cultural transformation, from welcoming women students to asserting academic freedom, Hesburgh laid the foundations for the College of Science’s accelerating research, discovery, and mission-driven entrepreneurship in the 21st century. 

Read More

Bohn appointed co-editor of Annual Reviews of Analytical Chemistry

Author: Gene Stowe

bohn_square

Paul W. Bohn, the Arthur J. Schmitt Professor of Chemical and Biomolecular Engineering and concurrent professor of chemistry and biochemistry, has been appointed to the editorship of Annual Reviews of Analytical Chemistry, the most highly cited publication in the field. Bohn, who has served four years on the journal’s international board, will serve a four-year term as co-editor.

Read More

New formulation of FDA-approved drug may help treat Niemann-Pick Type C disease

Author: William G. Gilroy

kasturi_square Niemann-Pick Type C (NPC) disease is a rare, fatal neurodegenerative disease for which there is currently no cure. NPC primarily strikes children before and during adolescence and affects one in every 150,000 children. Researchers Kasturi Haldar, the Nieuwland Professor in the Department of Biological Sciences and the Parsons-Quinn Director of the Boler-Parseghian Center for Rare and Neglected Diseases in the College of Science, and Dr. Suhail Alam and Michelle Getz in the Center for Rare and Neglected Diseases used existing FDA-approved drugs in a novel approach to treatment with promising results.

Read More

Prashant Kamat becomes editor-in-chief of ACS Energy Letters

Author: Marissa Gebhard

prashant_kamat2

 

Prashant Kamat, the Rev. John A. Zahm Professor of Science in the Department of Chemistry and Biochemistry and Radiation Laboratory at the University of Notre Dame, will serve as the inaugural editor-in-chief of ACS Energy Letters, a new peer-reviewed journal from the American Chemical Society (ACS). ACS Letters will enable the rapid publication of advances in energy research.

Read More

College of Science faculty awarded support from CTSI Molecular Therapeutics Program

Author: Richard Taylor

ctsi2

Notre Dame faculty from the Departments of Chemistry and Biochemistry and Biological Sciences have been awarded a grant from the Indiana Clinical and Translational Sciences Institute (CTSI).

Bradley Smith, the Emil T. Hofman Professor of Chemistry & Biochemistry and a researcher in the Warren Family Research Center for Drug Discovery and Development, received a grant from the Molecular Therapeutics Program of the Indiana CTSI for a project titled “Novel Drug Candidates for Treating Leishmaniasis.” 

 

 

Read More

COP21: SUCCESS FOR ADAPTATION

Author: Alex Gumm

Paris Agreement reflects University of Notre Dame's climate research assets. 

Notre Dame Global Adaptation Index is key to the success of the Agreement, providing knowledge, products and services for all of the signatories and other private sector and development actors working to achieve adaptation and resilience goals.

Read More

Cancer too complex for a magic bullet: Resources to support research are needed, expert says

Author: William G. Gilroy

Sharon Stack

Thursday (Feb. 4) marks World Cancer Day. World Cancer Day was established by the Paris Charter adopted at the World Summit Against Cancer for the New Millennium in Paris on Feb. 4, 2000. The goals of the charter are the promotion of research to cure as well as prevent the disease, upgrades to the provided services to the patients, the sensitization of the common opinion and the mobilization of the global community against cancer.

Read More